Vaxcyte
PCVX
#2054
Rank
NZ$17.23 B
Marketcap
NZ$115.82
Share price
-2.90%
Change (1 day)
63.55%
Change (1 year)

Market capitalization of Vaxcyte (PCVX)

Market cap: NZ$17.23 Billion

As of October 2026 Vaxcyte has a market cap of NZ$17.23 Billion. This makes Vaxcyte the world's 2054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vaxcyte from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.23 B62.33%
2025NZ$10.61 B-40.67%
2024NZ$17.89 B89.37%
2023NZ$9.44 B58.41%
2022NZ$5.96 B224.45%
2021NZ$1.83 B-2.01%
2020NZ$1.87 B

End of Day market cap according to different sources

On Oct 8th, 2026 the market cap of Vaxcyte was reported to be:

NZ$17.23 Billion
by Nasdaq info icon info icon
NZ$17.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.22 B-87.11%๐Ÿ‡บ๐Ÿ‡ธ USA